Author of the publication

New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors

, , , , , , and . Genes Chromosomes Cancer, 47 (5): 386--395 (2008)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Chibby, a novel antagonist of the Wnt pathway, is not involved in Wilms tumor development, , , and . Cancer Lett, 220 (1): 115--120 (2005)Target genes of the WNT/beta-catenin pathway in Wilms tumors, , , , , , and . Genes Chromosomes Cancer, 45 (6): 565--574 (2006)Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters, , , , , , , , and . Int J Cancer, 118 (8): 1954--1962 (2006)Novel familial WT1 read-through mutation associated with Wilms tumor and slow progressive nephropathy, , and . Am J Kidney Dis, 45 (6): 1100--1104 (2005)New prognostic markers revealed by evaluation of genes correlated with clinical parameters in Wilms tumors, , , , , , and . Genes Chromosomes Cancer, 47 (5): 386--395 (2008)WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact, , , , , and . Genes Chromosomes Cancer, 48 (12): 1102--1111 (2009)Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis, , , , , and . Genes Chromosomes Cancer, 46 (2): 163--170 (2007)Identification of limited regions of genetic aberrations in patients affected with Wilms' tumor using a tiling-path chromosome 22 array, , , , , , and . Int J Cancer, 119 (3): 571--578 (2006)